Climb Bio (CLYM) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Climb Bio (CLYM) Company Statistics | The Fly

Climb Bio

· CLYM

Dashboard

Financials

Ratios

Valuation

Statistics

660.517 M

-0.26%

General

Market Cap: $660.52M
Enterprise Value: $614.01M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -23.40%
ROE: -31.79%
ROIC: -26.89%
Current Ratio: 31.45
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 2.74
EV/EBITDA: -10.34

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $64.69M
Operating Income: -$64.76M
Net Profit: -$57.62M

Balance Sheet

Cash and Equivalents: $44.11M
Working Capital: $180.7M
Total Assets: $246.29M
Net Debt: -$42.79M
Total Liabilities: $6.75M
Total Equity: $239.55M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$52.7M
Cash Flow from Investing: -$29.42M
Cash Flow from Financing: $103.69M
Free Cash Flow: -$53.07M
Capital Expenditures: $369K